Expression of genes for cytokines and cytokine-related functions in leukocytes infected with Herpes simplex virus: Comparison between resistant and suscept3ible mouse strains

European Cytokine Network

Volumn 13, Issue 3, 2002, Pages 306-316

  Paludan, Søren R ^a   Melchjorsen, Jesper ^a   Malmgaard, Lene ^a   Mogensen, Soren C ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

cDNA arrays; Cytokines; Herpes simplex virus; Leukocytes

Indexed keywords

BINDING PROTEIN; CELL SURFACE PROTEIN; CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; CYTOKINE RECEPTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTEGRIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; IMMUNE SYSTEM; LEUKOCYTE; LEUKOCYTE FUNCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM CELL; PERITONEUM MACROPHAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ANIMALS; BASE SEQUENCE; CYTOKINES; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; LEUKOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMPLEXVIRUS; SPECIES SPECIFICITY;

ANIMALIA; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; MURINAE; SIMPLEXVIRUS;

EID: 0036635305     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Herpes simplex viruses and their replication
2. The genome sequence of Herpes simplex virus type 2
3. Repression of viral transcription during Herpes simplex virus latency
4. Genital Herpes simplex virus infections: Clinical manifestations, course, and complications
5. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response
6. Focal necrotic hepatitis in mice as a biological marker for differentiation of Herpes virus hominis type 1 and type 2
7. Macrophage control of Herpes simplex virus type 1 replication in the peripheral nervous system
8. Interferon-γ enhances resolution of Herpes simplex virus type 2 infection of the murine genital tract
9. Mice lacking inducible nitric-oxide synthase are more susceptible to Herpes simplex virus infection despite enhanced Th1 cell responses
10. Requirements for the induction of interleukin-6 by Herpes simplex virus-infected leukocytes
11. Virus-cell interactions regulating induction of tumor necrosis factor-α production in macrophages infected with Herpes simplex virus
12. Role of macrophages in restricting Herpes simplex virus type 1 growth after ocular infection
13. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
14. Natural interferon α/β-producing cells link innate and adaptive immunity
15. Innate immunity to viruses: Control of vaccinia virus infection by γδ T cells
16. TCRγδ cells and viruses
17. Cellular responses to interferon-γ
18. Molecular pathways in virus-induced cytokine production
19. Virus-cell interactions: Impact on cytokine production, immune evasion and tumor growth
20. Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of Herpes simplex virus type 1 in IL-6 knockout mice
21. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital Herpes simplex virus type 2 infection in mice but are not required for the development of acquired γ interferon-mediated protective immunity
22. The plasticity of dendritic cell responses to pathogens and their components
23. Genetics of natural resistance to herpesvirus infections in mice
24. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor-2
25. Interleukin-18
26. Innate immune response of the human host to exposure with Herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction
27. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAKSTAT signaling pathway
28. Inhibition of NO production in macrophages by IL-13 is counteracted by HSV infection through TNF-α-induced activation of NF-κB
29. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T cell-mediated protective immunity against Herpes simplex virus type 2 in vivo
30. Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0
31. NF-κB activation is responsible for the synergistic effect of Herpes simplex virus type 2 infection on interferon-γ-induced nitric oxide production
32. Role of nitric oxide in pathogenesis of Herpes simplex virus encephalitis in rats
33. Difference between Herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome
34. Herpes simplex virus type 2 induces interleukin-12 in macrophages through a mechanism involving NF-κB
35. Interleukin-12 exhibits potent antiviral activity in experimental Herpesvirus infections
36. + T cell-mediated protective immunity against Herpes simplex virus-2 challenge
37. Herpes simplex virus type 2 synergizes with interferon-γ in the induction of nitric oxide production in mouse macrophages through autocrine secretion of tumour necrosis factor-α